Armata Pharmaceuticals (ARMP) Return on Equity (2014 - 2026)

Armata Pharmaceuticals has disclosed Return on Equity across 13 years of filings, most recently posting 0.0% for Q1 2026.

• Return on Equity for Q1 2026 came in at 0.0%, down 1.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (down 1.0% YoY), and the FY2025 annual result was 0.0%, down 1.0% from the prior year.
• Return on Equity came in at 0.0% for Q1 2026 at Armata Pharmaceuticals, down from 0.0% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.02% in Q4 2023 to a low of 0.13% in Q3 2023.
• The 5-year median for Return on Equity is 0.0% (2025), against an average of 0.01%.
• Across the five-year window, Return on Equity fell 12 bps in 2023 and climbed 14 bps in 2024, its largest moves.
• Armata Pharmaceuticals' Return on Equity stood at 0.01% in 2022, then soared by 316 bps to 0.02% in 2023, then slumped by 45 bps to 0.01% in 2024, then tumbled by 68 bps to 0.0% in 2025, then tumbled by 38 bps to 0.0% in 2026.
• The last three Return on Equity figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.